# OnCo record paper-rolapitant-study-3-schwartzberg-lancet-oncol-2015 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-rolapitant-study-3-schwartzberg-lancet-oncol-2015/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-rolapitant-study-3-schwartzberg-lancet-oncol-2015" ;
  schema:name "Rolapitant for prevention of chemotherapy-induced nausea and vomiting after moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens: a randomised, active-controlled, double-blind, phase 3 trial"@en ;
  schema:description "Adding a single rolapitant tablet to the standard two anti-sickness drugs kept 71 percent of patients free of vomiting and rescue medicine in the days after moderately strong chemotherapy, against 62 percent without it."@en ;
  schema:url <https://onco.cc/key-papers/paper-rolapitant-study-3-schwartzberg-lancet-oncol-2015/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S1470-2045(15)00034-0>, <https://pubmed.ncbi.nlm.nih.gov/26272768/>, <https://clinicaltrials.gov/study/NCT01500226> ;
  schema:sameAs <https://doi.org/10.1016/S1470-2045(15)00034-0> ;
  schema:datePublished "2015"^^xsd:gYear ;
  schema:author "Schwartzberg LS, Modiano MR, Rapoport BL, et al." ;
  onco:sections <https://onco.cc/fronts/supportive-care/> ;
  onco:drugs <https://onco.cc/drugs/rolapitant/> ;
  onco:trials <https://onco.cc/trials/ts-p04834/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .